Blood Filtration And Purification Market Report 2026

Blood Filtration And Purification Market Overview

• Blood Filtration And Purification market size has reached to $4.38 billion in 2025 • Expected to grow to $7.12 billion in 2030 at a compound annual growth rate (CAGR) of 10.2% • Growth Driver: Increasing Prevalence Of Blood-Related Disorders Driving The Growth Of The Market Due To Aging Global Population And Rising Disease Incidence • Market Trend: Advancing Home Dialysis With Innovative, User-Friendly Technology Solutions • North America was the largest region in 2025 and Asia Pacific is the fastest growing region.

What Is Covered Under Blood Filtration And Purification Market?

Blood filtration and purification is a medical process that removes impurities, toxins, excess fluids, or harmful substances from the blood to restore its normal composition and improve patient health. It uses specialized devices and techniques to clean the blood outside the body and then return it, helping manage various acute and chronic conditions. This therapy is widely used to support organ function, control infections, and maintain balance in critically ill patients. The main products of the blood filtration and purification are filtration kits and reagents, membranes, filters and consumables, sample preparation systems, and specialty assays and columns. Filtration kits and reagents are specialized collections of components and chemical substances used in medical and laboratory processes for filtering and preparing blood or biological samples. The various applications involved are infectious disease diagnostics, toxicology and immunodiagnostics, cancer diagnostics, genetic or molecular diagnostics, and others, and they are used by several end users such as clinical diagnostic labs, hospitals, research and academic institutes, and others.

What Is The Blood Filtration And Purification Market Growth Forecast?

The blood filtration and purification market size is expected to see rapid growth in the next few years. It will grow to $7.12 billion in 2030 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to development of automated and high-throughput filtration systems, rising research in genetic and molecular diagnostics, growing investment in clinical diagnostic labs, increasing demand for disposable and specialized kits, technological advancements in membrane and assay design. Major trends in the forecast period include growing adoption of automated blood filtration systems, increasing demand for disposable filtration kits and reagents, rising use of specialty assays and columns in diagnostics, expansion of membranes, filters, and consumables segment, enhanced focus on sample preparation and blood purification efficiency.

Global Blood Filtration And Purification Market Segmentation

1) By Product: Filtration Kits And Reagents, Membranes, Filters And Consumables, Sample Preparation Systems, Specialty Assays And Columns 2) By Application: Infectious Disease Diagnostics, Toxicology And Immunodiagnostics, Cancer Diagnostics, Genetic Or Molecular Diagnostics, Others Applications 3) By End User: Clinical Diagnostic Labs, Hospitals, Research And Academic Institutes, Other End Users Subsegments: 1) By Filtration Kits And Reagents: Disposable Filtration Kits, Reagent Kits For Blood Purification, Enzyme-Based Reagents, Chemical Reagents, Buffer Solutions 2) By Membranes, Filters And Consumables: Hollow Fiber Membranes, Flat Sheet Membranes, Microfiltration Filters, Ultrafiltration Filters, Nanofiltration Filters, Filter Cartridges, Consumable Accessories 3) By Sample Preparation Systems: Automated Sample Preparation Instruments, Manual Sample Preparation Devices, Centrifugation Systems, Blood Separation Units, Cell Sorting Systems 4) By Specialty Assays And Columns: Affinity Chromatography Columns, Ion Exchange Columns, Size Exclusion Columns, Immunoaffinity Assays, Enzymatic Assays

What Is The Driver Of The Blood Filtration And Purification Market?

The increasing prevalence of blood-related disorders is expected to propel the growth of the blood filtration and purification market going forward. Blood-related disorders are medical conditions that impact the blood’s cells, components, or functions. The prevalence of blood-related disorders is rising due to the aging global population, as older individuals are more susceptible to conditions affecting blood health, leading to higher incidence rates and greater demand for diagnosis and treatment. Blood filtration and purification support blood-related disorders by effectively eliminating toxins and harmful components from the blood, helping to restore healthy blood function and reduce disease symptoms. For instance, in November 2024, the American Society of Hematology, a US-based non-profit organization, projected that new leukemia cases in the United States will rise to 519,540 by 2050. Therefore, the increasing prevalence of blood-related disorders is driving the growth of the blood filtration and purification industry.

Key Players In The Global Blood Filtration And Purification Market

Major companies operating in the blood filtration and purification market are Thermo Fisher Scientific Inc., Asahi Kasei Corporation, Fresenius SE & Co. KGaA, Toray Industries Inc., Baxter International Inc., DaVita Inc., Kaneka Corporation, Nipro Corporation, Nikkiso Co. Ltd., Jafron Biomedical Co. Ltd., Satellite Healthcare Inc., B. Braun Melsungen AG, Biotage AB, CytoSorbents Europe GmbH, Medica S.p.A., SWS Medical Group, Spectral Medical Inc., ExThera Medical Corporation, Infomed SA, Baihe Medical Co. Ltd., Guangdong Biolight Meditech Co. Ltd.

Global Blood Filtration And Purification Market Trends and Insights

Major companies operating in the blood filtration and purification market are focusing on developing advanced solutions, such as enhanced touchscreen interfaces, to deliver user-friendly systems that simplify dialysis procedures and improve the patient experience in home-based therapies. The enhanced touchscreen interface is an upgraded, user-friendly display with improved graphics and intuitive navigation that simplifies operating the home hemodialysis system. For instance, in August 2023, Fresenius Medical Care, a Germany-based healthcare company, announced the Food and Drug Administration (FDA) clearance for VersiHD with GuideMe Software. It is a state-of-the-art home hemodialysis system that integrates a reliable dialysis machine with an intuitive, self-guided interface to make treatment easier for patients and caregivers. It offers clear, step-by-step visual instructions to improve usability, increase patient confidence, and shorten training time, helping more people manage dialysis at home. Building on NxStage’s long-standing expertise in home hemodialysis, this system provides effective blood filtration and purification for individuals with chronic kidney disease, allowing them to safely and comfortably perform dialysis independently.

What Are Latest Mergers And Acquisitions In The Blood Filtration And Purification Market?

In December 2024, GVS S.p.A., an Italy-based filtration solutions company, acquired Haemonetics Corporation's whole blood business for an undisclosed amount. Through this acquisition, GVS S.p.A. aims to strengthen its product portfolio by adding Haemonetics' unique blood collection, processing, filtration, and transfusion technologies. Haemonetics Corporation is a US-based company that provides blood management solutions such as blood filtration and purification.

Regional Outlook

North America was the largest region in the blood filtration and purification market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Blood Filtration And Purification Market?

The blood filtration and purification market consists of revenues earned by entities by provide services such as therapeutic blood purification procedures, separation services, and support for biopharmaceutical manufacturing. The market value includes the value of related goods sold by the service provider or included within the service offering. The blood filtration and purification market also includes sales of blood filters, diagnostic tools, and replacement therapy accessories. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.